ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Mycoplasma Pneumonia Live Vaccine Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-4U14417
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Mycoplasma Pneumonia Live Vaccine Market Research Report 2023
BUY CHAPTERS

Global Swine Mycoplasma Pneumonia Live Vaccine Market Research Report 2025

Code: QYRE-Auto-4U14417
Report
April 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zoetis Inc
Boehringer Ingelheim
Merck
Hipra
Ceva Santé Animale
Harbin Pharmaceutical Group
Qilu Animal Health Products
Guangdong Winsun Bio Pharmaceutical
Jilin HeYuan Bioengineering
Jofunhwa Biotechnology

Swine Mycoplasma Pneumonia Live Vaccine Market Size

The global market for Swine Mycoplasma Pneumonia Live Vaccine was valued at US$ 248 million in the year 2024 and is projected to reach a revised size of US$ 376 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Swine Mycoplasma Pneumonia Live Vaccine Market

Swine Mycoplasma Pneumonia Live Vaccine Market

Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig"s immune system to recognize and fight against the bacteria that causes pneumonia.
North American market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Swine Mycoplasma Pneumonia Live Vaccine include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Santé Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical, Jilin HeYuan Bioengineering, Jofunhwa Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Mycoplasma Pneumonia Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Mycoplasma Pneumonia Live Vaccine.
The Swine Mycoplasma Pneumonia Live Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Mycoplasma Pneumonia Live Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Mycoplasma Pneumonia Live Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Swine Mycoplasma Pneumonia Live Vaccine Market Report

Report Metric Details
Report Name Swine Mycoplasma Pneumonia Live Vaccine Market
Accounted market size in year US$ 248 million
Forecasted market size in 2031 US$ 376 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
by Type
  • 168 Strains
  • RM48 Strains
  • Other
by Application
  • Piglets
  • Adult Pigs
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Santé Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical, Jilin HeYuan Bioengineering, Jofunhwa Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Swine Mycoplasma Pneumonia Live Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Swine Mycoplasma Pneumonia Live Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Swine Mycoplasma Pneumonia Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Swine Mycoplasma Pneumonia Live Vaccine Market growing?

Ans: The Swine Mycoplasma Pneumonia Live Vaccine Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Swine Mycoplasma Pneumonia Live Vaccine Market size in 2031?

Ans: The Swine Mycoplasma Pneumonia Live Vaccine Market size in 2031 will be US$ 376 million.

Who are the main players in the Swine Mycoplasma Pneumonia Live Vaccine Market report?

Ans: The main players in the Swine Mycoplasma Pneumonia Live Vaccine Market are Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Santé Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical, Jilin HeYuan Bioengineering, Jofunhwa Biotechnology

What are the Application segmentation covered in the Swine Mycoplasma Pneumonia Live Vaccine Market report?

Ans: The Applications covered in the Swine Mycoplasma Pneumonia Live Vaccine Market report are Piglets, Adult Pigs

What are the Type segmentation covered in the Swine Mycoplasma Pneumonia Live Vaccine Market report?

Ans: The Types covered in the Swine Mycoplasma Pneumonia Live Vaccine Market report are 168 Strains, RM48 Strains, Other

Recommended Reports

Porcine Vaccines

Respiratory Vaccines

Animal Vaccine Tech

1 Swine Mycoplasma Pneumonia Live Vaccine Market Overview
1.1 Product Definition
1.2 Swine Mycoplasma Pneumonia Live Vaccine by Type
1.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 168 Strains
1.2.3 RM48 Strains
1.2.4 Other
1.3 Swine Mycoplasma Pneumonia Live Vaccine by Application
1.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Piglets
1.3.3 Adult Pigs
1.4 Global Market Growth Prospects
1.4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production Estimates and Forecasts (2020-2031)
1.4.4 Global Swine Mycoplasma Pneumonia Live Vaccine Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Manufacturers (2020-2025)
2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Swine Mycoplasma Pneumonia Live Vaccine, Industry Ranking, 2023 VS 2024
2.4 Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Date of Enter into This Industry
2.9 Swine Mycoplasma Pneumonia Live Vaccine Market Competitive Situation and Trends
2.9.1 Swine Mycoplasma Pneumonia Live Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Swine Mycoplasma Pneumonia Live Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Swine Mycoplasma Pneumonia Live Vaccine Production by Region
3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2020-2031)
3.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Swine Mycoplasma Pneumonia Live Vaccine by Region (2026-2031)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Swine Mycoplasma Pneumonia Live Vaccine Production Volume by Region (2020-2031)
3.4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Swine Mycoplasma Pneumonia Live Vaccine by Region (2026-2031)
3.5 Global Swine Mycoplasma Pneumonia Live Vaccine Market Price Analysis by Region (2020-2025)
3.6 Global Swine Mycoplasma Pneumonia Live Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Swine Mycoplasma Pneumonia Live Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Swine Mycoplasma Pneumonia Live Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Swine Mycoplasma Pneumonia Live Vaccine Production Value Estimates and Forecasts (2020-2031)
4 Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region
4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2020-2031)
4.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2020-2025)
4.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2020-2031)
5.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2020-2025)
5.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Type (2026-2031)
5.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Type (2020-2031)
5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2020-2031)
5.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2020-2025)
5.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Type (2026-2031)
5.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type (2020-2031)
5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2020-2031)
6 Segment by Application
6.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2020-2031)
6.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2020-2025)
6.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production by Application (2026-2031)
6.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Application (2020-2031)
6.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2020-2031)
6.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2020-2025)
6.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Application (2026-2031)
6.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application (2020-2031)
6.3 Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Zoetis
7.1.1 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.1.2 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Zoetis Main Business and Markets Served
7.1.5 Zoetis Recent Developments/Updates
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.2.2 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Boehringer Ingelheim Main Business and Markets Served
7.2.5 Boehringer Ingelheim Recent Developments/Updates
7.3 Merck
7.3.1 Merck Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.3.2 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Merck Main Business and Markets Served
7.3.5 Merck Recent Developments/Updates
7.4 HIPRA
7.4.1 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.4.2 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.4.4 HIPRA Main Business and Markets Served
7.4.5 HIPRA Recent Developments/Updates
7.5 Ceva Santé Animale
7.5.1 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.5.2 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.5.3 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Ceva Santé Animale Main Business and Markets Served
7.5.5 Ceva Santé Animale Recent Developments/Updates
7.6 Harbin Pharmaceutical Group
7.6.1 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.6.2 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.6.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.7 Qilu Animal Health Products
7.7.1 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.7.2 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Qilu Animal Health Products Main Business and Markets Served
7.7.5 Qilu Animal Health Products Recent Developments/Updates
7.8 Guangdong Winsun Bio-Pharmaceutical
7.8.1 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.8.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Guangdong Winsun Bio-Pharmaceutical Main Business and Markets Served
7.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
7.9 Jilin HeYuan Bioengineering
7.9.1 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.9.2 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Jilin HeYuan Bioengineering Main Business and Markets Served
7.9.5 Jilin HeYuan Bioengineering Recent Developments/Updates
7.10 Jofunhwa Biotechnology
7.10.1 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Company Information
7.10.2 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Portfolio
7.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Jofunhwa Biotechnology Main Business and Markets Served
7.10.5 Jofunhwa Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Chain Analysis
8.2 Swine Mycoplasma Pneumonia Live Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Swine Mycoplasma Pneumonia Live Vaccine Production Mode & Process Analysis
8.4 Swine Mycoplasma Pneumonia Live Vaccine Sales and Marketing
8.4.1 Swine Mycoplasma Pneumonia Live Vaccine Sales Channels
8.4.2 Swine Mycoplasma Pneumonia Live Vaccine Distributors
8.5 Swine Mycoplasma Pneumonia Live Vaccine Customer Analysis
9 Swine Mycoplasma Pneumonia Live Vaccine Market Dynamics
9.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Trends
9.2 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
9.3 Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
9.4 Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Zoetis Inc
Boehringer Ingelheim
Merck
Hipra
Ceva Santé Animale
Harbin Pharmaceutical Group
Qilu Animal Health Products
Guangdong Winsun Bio Pharmaceutical
Jilin HeYuan Bioengineering
Jofunhwa Biotechnology
List of Tables
 Table 1. Global Swine Mycoplasma Pneumonia Live Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Swine Mycoplasma Pneumonia Live Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Swine Mycoplasma Pneumonia Live Vaccine Production Capacity (K Units) by Manufacturers in 2024
 Table 4. Global Swine Mycoplasma Pneumonia Live Vaccine Production by Manufacturers (2020-2025) & (K Units)
 Table 5. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Swine Mycoplasma Pneumonia Live Vaccine, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Swine Mycoplasma Pneumonia Live Vaccine as of 2024)
 Table 10. Global Market Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturers (US$/Unit) & (2020-2025)
 Table 11. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Product Offered and Application
 Table 13. Global Key Manufacturers of Swine Mycoplasma Pneumonia Live Vaccine, Date of Enter into This Industry
 Table 14. Global Swine Mycoplasma Pneumonia Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region (2020-2025)
 Table 19. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Swine Mycoplasma Pneumonia Live Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) by Region (2020-2025)
 Table 23. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region (2020-2025)
 Table 24. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) Forecast by Region (2026-2031)
 Table 25. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Swine Mycoplasma Pneumonia Live Vaccine Market Average Price (US$/Unit) by Region (2020-2025)
 Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Market Average Price (US$/Unit) by Region (2026-2031)
 Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2020-2025) & (K Units)
 Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Region (2020-2025)
 Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Forecasted Consumption by Region (2026-2031) & (K Units)
 Table 32. Global Swine Mycoplasma Pneumonia Live Vaccine Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
 Table 34. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2020-2025) & (K Units)
 Table 35. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2026-2031) & (K Units)
 Table 36. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
 Table 37. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2020-2025) & (K Units)
 Table 38. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2026-2031) & (K Units)
 Table 39. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 40. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2020-2025) & (K Units)
 Table 41. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region (2026-2031) & (K Units)
 Table 42. Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
 Table 43. Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2020-2025) & (K Units)
 Table 44. Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption by Country (2026-2031) & (K Units)
 Table 45. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) by Type (2020-2025)
 Table 46. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) by Type (2026-2031)
 Table 47. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Type (2020-2025)
 Table 48. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Type (2026-2031)
 Table 49. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type (2020-2025)
 Table 52. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Type (2026-2031)
 Table 53. Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 54. Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 55. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) by Application (2020-2025)
 Table 56. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) by Application (2026-2031)
 Table 57. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Application (2020-2025)
 Table 58. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Application (2026-2031)
 Table 59. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application (2020-2025)
 Table 62. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Application (2026-2031)
 Table 63. Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 64. Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 65. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 66. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 67. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 68. Zoetis Main Business and Markets Served
 Table 69. Zoetis Recent Developments/Updates
 Table 70. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 71. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 72. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Main Business and Markets Served
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Merck Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 76. Merck Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 77. Merck Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Main Business and Markets Served
 Table 79. Merck Recent Developments/Updates
 Table 80. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 81. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 82. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. HIPRA Main Business and Markets Served
 Table 84. HIPRA Recent Developments/Updates
 Table 85. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 86. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 87. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Santé Animale Main Business and Markets Served
 Table 89. Ceva Santé Animale Recent Developments/Updates
 Table 90. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 91. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 92. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Harbin Pharmaceutical Group Main Business and Markets Served
 Table 94. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 95. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 96. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 97. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Qilu Animal Health Products Main Business and Markets Served
 Table 99. Qilu Animal Health Products Recent Developments/Updates
 Table 100. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 101. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 102. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Guangdong Winsun Bio-Pharmaceutical Main Business and Markets Served
 Table 104. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
 Table 105. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 106. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 107. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Jilin HeYuan Bioengineering Main Business and Markets Served
 Table 109. Jilin HeYuan Bioengineering Recent Developments/Updates
 Table 110. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Company Information
 Table 111. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Specification and Application
 Table 112. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Jofunhwa Biotechnology Main Business and Markets Served
 Table 114. Jofunhwa Biotechnology Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Swine Mycoplasma Pneumonia Live Vaccine Distributors List
 Table 118. Swine Mycoplasma Pneumonia Live Vaccine Customers List
 Table 119. Swine Mycoplasma Pneumonia Live Vaccine Market Trends
 Table 120. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers
 Table 121. Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
 Table 122. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Swine Mycoplasma Pneumonia Live Vaccine
 Figure 2. Global Swine Mycoplasma Pneumonia Live Vaccine Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Type: 2024 VS 2031
 Figure 4. 168 Strains Product Picture
 Figure 5. RM48 Strains Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application: 2024 VS 2031
 Figure 9. Piglets
 Figure 10. Adult Pigs
 Figure 11. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Swine Mycoplasma Pneumonia Live Vaccine Production Capacity (K Units) & (2020-2031)
 Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Production (K Units) & (2020-2031)
 Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 16. Swine Mycoplasma Pneumonia Live Vaccine Report Years Considered
 Figure 17. Swine Mycoplasma Pneumonia Live Vaccine Production Share by Manufacturers in 2024
 Figure 18. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Share by Manufacturers (2024)
 Figure 19. Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2024
 Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Swine Mycoplasma Pneumonia Live Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Swine Mycoplasma Pneumonia Live Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)
 Figure 24. Global Swine Mycoplasma Pneumonia Live Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan Swine Mycoplasma Pneumonia Live Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (K Units)
 Figure 30. Global Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 32. North America Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 34. Canada Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 35. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 36. Europe Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Country (2020-2031)
 Figure 37. Germany Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 38. France Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 39. U.K. Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 40. Italy Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 41. Russia Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 42. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 43. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Region (2020-2031)
 Figure 44. China Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 45. Japan Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 46. South Korea Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 47. China Taiwan Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 48. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 49. India Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 50. Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 51. Latin America, Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 53. Brazil Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 54. Turkey Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 55. GCC Countries Swine Mycoplasma Pneumonia Live Vaccine Consumption and Growth Rate (2020-2031) & (K Units)
 Figure 56. Global Production Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Type (2020-2031)
 Figure 57. Global Production Value Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Type (2020-2031)
 Figure 58. Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Production Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Application (2020-2031)
 Figure 60. Global Production Value Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Application (2020-2031)
 Figure 61. Global Swine Mycoplasma Pneumonia Live Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 62. Swine Mycoplasma Pneumonia Live Vaccine Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024
Swine Hyopneumoniae Mycoplasma Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Research Report 2025
Global Porcine Circovirus Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024
Global Live Attenuated Vaccine for Pig Market Research Report 2024
Global Mycoplasma Galliscepticum Vaccine Market Research Report 2024
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mycoplasma Pneumonia Test kits Market Research Report 2024
Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025
Porcine Reproductive Respiratory Syndrome PRRS Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Live Vaccines Market Research Report 2025
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Swine Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine Live Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions